Therapy News and Research

RSS

The Life Sciences; Where are we now, and where are we going?

As part of our SLAS Europe 2022 coverage, we spoke to Gerrit Gutzke and Michael Bussmann from Azenta Life Sciences about the products they offer for life sciences research.

From Society for Laboratory Automation and Screening (SLAS) 7 Jul 2022

Gestures can help to get the message across for people with language disorders

When words fail, gestures can help to get the message across - especially for people who have a language disorder. An international research team has now shown that listeners attend the gestures of people with aphasia more often and for much longer than previously thought. This has implications for the use of gestures in speech therapy.

7 Jul 2022

Researchers find a way to kill recurring prostate cancer with a lot of iron

Prostate cancer can come back from common hormone deprivation therapy with a vengeance and no clear treatment option, but scientists have early evidence that one way to kill these recurring cancer cells may be with a lot of iron.

7 Jul 2022

Less sex during menopause transition not associated with increased risk of sexual pain

Having sex less often during the transition to menopause is not associated with an increased risk of developing pain with intercourse, according to a new study published recently by the Journal of Obstetrics and Gynecology.

7 Jul 2022

Transgender patients report better mental health after gender-affirming facial feminization surgery

A UCLA study offers the first evidence that transgender patients who receive gender-affirming facial feminization surgery reported better mental health after their procedures.

6 Jul 2022

Study: Lactobacilli living in female urinary tract's microbiome can kill nearby pathogenic bacteria

Lactobacilli that live in the human female urinary tract's microbiome are competitive and kill nearby pathogenic bacteria, according to the first study of its kind by a team led by microbiologist Dr. Tanya Sysoeva of The University of Alabama in Huntsville.

6 Jul 2022

$3.1 million grant will help researchers to study signs of heart damage in young breast cancer survivors

A 5-year, $3.1 million grant from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, will enable researchers from Atrium Health Wake Forest Baptist's NCI-designated Comprehensive Cancer Center, Virginia Commonwealth University Massey Cancer Center and Duke Cancer Institute to collaborate in a first-of-its-kind prospective study to look for the earliest signs of heart vessel damage in young, pre-menopausal breast cancer survivors.

6 Jul 2022

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators.

6 Jul 2022

Pregnancies following frozen embryo transfer have higher risk of hypertensive disorders

Concerns have been raised over the past few years that pregnancies derived from frozen embryo transfers in IVF might increase the maternal risk of hypertensive disorders, particularly pre-eclampsia, complications which may have severe consequences for the mother and fetus.

6 Jul 2022

‘Hypervitaminosis D’ is on the rise and linked to serious health issues

'Overdosing' on vitamin D supplements is both possible and harmful, warn doctors in the journal BMJ Case Reports after they treated a man who needed hospital admission for his excessive vitamin D intake.

6 Jul 2022

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

In a new study, the effectiveness of low low-density lipoprotein cholesterol levels in reducing the risk of atherosclerotic vascular events was explored.

6 Jul 2022

Beyond COVID-19: the potential future applications of mRNA vaccines

Researchers described the production, mechanisms, and potential applications of mRNA vaccines.

6 Jul 2022

Intrahost genetic diversity and evolution of the SARS-CoV-2 B.1.517 lineage during chronic infection of an immunocompromised individual

Researchers investigated the intrahost evolution and genetic diversity of the SARS-CoV-2 B.1.517 variant in an immunosuppressed person with chronic COVID-19.

6 Jul 2022

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

In a recent study posted to the medRxiv* pre-print server, researchers developed a mechanistic mathematical model to predict the course of vaccine-induced immunity in healthy and immunosuppressed patients for the long term, exceeding the time frames for which clinical data is currently available.

5 Jul 2022

What role does human microbiota play in COVID-19 severity?

In a recent study published in the journal Advanced Science, researchers explored the dynamic changes in the respiratory tract and gut microbiota in coronavirus disease 2019 (COVID-19) patients. They observed and analyzed these changes during different disease progression stages among patients with differential disease severities.

5 Jul 2022

Novel inhalable COVID-19 vaccine

A recent study published in the Nature Biomedical Engineering journal illustrated a novel inhalable SARS-CoV-2 vaccine candidate centered on exosomes (Exos) coupled with recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD).

5 Jul 2022

Scientists uncover HIV’s sweet spot

HIV researchers have long been trying to identify the specific cells that the virus prefers to infect and hide in. They know that HIV favors a special type of immune cells called memory CD4 T cells.

5 Jul 2022

What causes insomnia and how to treat it?

A new study evaluates the symptoms of insomnia and its treatment as reported by patients in primary care settings.

5 Jul 2022

Trial: Convalescent plasma does not improve survival or recovery in hospitalized COVID-19 patients

Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover, according to a national clinical trial led by Vanderbilt University Medical Center and published in the journal CHEST.

5 Jul 2022

Study results underscore the challenges in treating interstitial pneumonia with autoimmune features

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat.

5 Jul 2022

Therapy News and Research

The Life Sciences; Where are we now, and where are we going?

Gestures can help to get the message across for people with language disorders

Researchers find a way to kill recurring prostate cancer with a lot of iron

Less sex during menopause transition not associated with increased risk of sexual pain

Transgender patients report better mental health after gender-affirming facial feminization surgery

Study: Lactobacilli living in female urinary tract's microbiome can kill nearby pathogenic bacteria

$3.1 million grant will help researchers to study signs of heart damage in young breast cancer survivors

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

Pregnancies following frozen embryo transfer have higher risk of hypertensive disorders

‘Hypervitaminosis D’ is on the rise and linked to serious health issues

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

Beyond COVID-19: the potential future applications of mRNA vaccines

Intrahost genetic diversity and evolution of the SARS-CoV-2 B.1.517 lineage during chronic infection of an immunocompromised individual

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

What role does human microbiota play in COVID-19 severity?

Novel inhalable COVID-19 vaccine

Scientists uncover HIV’s sweet spot

What causes insomnia and how to treat it?

Trial: Convalescent plasma does not improve survival or recovery in hospitalized COVID-19 patients

Study results underscore the challenges in treating interstitial pneumonia with autoimmune features

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News